BE894376A - Preparation pharmaceutique - Google Patents
Preparation pharmaceutiqueInfo
- Publication number
- BE894376A BE894376A BE0/208995A BE208995A BE894376A BE 894376 A BE894376 A BE 894376A BE 0/208995 A BE0/208995 A BE 0/208995A BE 208995 A BE208995 A BE 208995A BE 894376 A BE894376 A BE 894376A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical preparation
- pharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30149881A | 1981-09-14 | 1981-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE894376A true BE894376A (fr) | 1983-03-14 |
Family
ID=23163649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/208995A BE894376A (fr) | 1981-09-14 | 1982-09-13 | Preparation pharmaceutique |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS5857315A (fr) |
AT (1) | AT385199B (fr) |
BE (1) | BE894376A (fr) |
BG (1) | BG60526B2 (fr) |
CH (1) | CH652025A5 (fr) |
DE (1) | DE3232873A1 (fr) |
FR (1) | FR2512676B1 (fr) |
GB (1) | GB2105590B (fr) |
IT (1) | IT1158048B (fr) |
MX (1) | MX9203173A (fr) |
NL (1) | NL190746C (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3659B (en) | 1991-01-23 | 1996-01-25 | Isis Pharma Gmbh | Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6143108A (ja) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | 医薬品製剤及びその製造法 |
GB8507779D0 (en) * | 1985-03-26 | 1985-05-01 | Fujisawa Pharmaceutical Co | Drug carrier |
EP0198769A3 (fr) * | 1985-04-12 | 1987-09-02 | Forest Laboratories, Inc. | Compositions thérapeutiques flottantes à libération prolongée |
US4983400A (en) * | 1986-06-16 | 1991-01-08 | Merck & Co., Inc. | Controlled release combination of carbidopa/levodopa |
SE460947B (sv) * | 1986-08-26 | 1989-12-11 | Lejus Medical Ab | En multiple-unit-dos komposition av l-dopa |
DE3642668A1 (de) * | 1986-12-13 | 1988-06-23 | Kamprad Joachim | Schmerzmittel fuer menschen |
ATE81971T1 (de) * | 1987-12-31 | 1992-11-15 | Asta Medica Ag | Synergistische kombination von decarboxylasehemmern und l-dopa-pellets. |
US5368861A (en) * | 1989-10-26 | 1994-11-29 | Nippon Shinyaku Co., Ltd. | Gastric preparation with sustained release |
US5227167A (en) * | 1991-06-11 | 1993-07-13 | Alza Corporation | Long-term delivery device including hydrophobic loading dose |
US5169638A (en) * | 1991-10-23 | 1992-12-08 | E. R. Squibb & Sons, Inc. | Buoyant controlled release powder formulation |
SE9203594D0 (sv) * | 1992-11-30 | 1992-11-30 | Christer Nystroem | Laekemedel i dispersa system |
AU692483B2 (en) * | 1993-10-29 | 1998-06-11 | R.P. Scherer Corporation | Gelatin capsule fill able to foam |
JPH09504286A (ja) * | 1993-10-29 | 1997-04-28 | レキット アンド コールマン プロダクツ リミテッド | 発泡しうるゼラチンカプセル充填物 |
US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
US5840756A (en) * | 1995-07-21 | 1998-11-24 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition of L-DOPA ester |
EP1560569A4 (fr) * | 2002-10-11 | 2006-03-22 | Depomed Dev Ltd | Forme gastro-retentive pour administrer du levodopa |
DE102004039196B4 (de) | 2004-08-12 | 2008-07-31 | Dr.Kamprad Kg | Neue Formulierung für L-Tryptophan |
DE102010023828A1 (de) * | 2010-06-15 | 2011-12-15 | IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH | Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält |
DE102014003744A1 (de) | 2014-03-10 | 2015-09-10 | Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) | Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts |
DE102022103658A1 (de) | 2022-02-16 | 2023-08-17 | Joachim Kamprad | Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH409996A (de) * | 1961-06-16 | 1966-03-31 | Hoffmann La Roche | Verfahren zur Herstellung von substituierten Hydrazinen |
US3557292A (en) * | 1968-08-16 | 1971-01-19 | Hoffmann La Roche | Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine |
US3632778A (en) * | 1970-06-10 | 1972-01-04 | Hoffmann La Roche | Tablets containing l-dopa |
ZA713877B (en) * | 1970-07-24 | 1972-03-29 | Hoffmann La Roche | Pharmaceutical composition |
DE2305209A1 (de) * | 1972-02-14 | 1973-08-23 | Hoffmann La Roche | Pharmazeutisches praeparat |
CA1018456A (en) * | 1972-06-26 | 1977-10-04 | Hans Lowey | Prolonged release lozenges |
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
US4126672A (en) * | 1976-02-04 | 1978-11-21 | Hoffmann-La Roche Inc. | Sustained release pharmaceutical capsules |
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
US4140755A (en) * | 1976-02-13 | 1979-02-20 | Hoffmann-La Roche Inc. | Sustained release tablet formulations |
-
1982
- 1982-08-13 CH CH4867/82A patent/CH652025A5/de not_active IP Right Cessation
- 1982-08-26 NL NL8203343A patent/NL190746C/xx not_active IP Right Cessation
- 1982-09-03 DE DE19823232873 patent/DE3232873A1/de not_active Ceased
- 1982-09-07 IT IT23147/82A patent/IT1158048B/it active Protection Beyond IP Right Term
- 1982-09-10 FR FR8215334A patent/FR2512676B1/fr not_active Expired
- 1982-09-13 BE BE0/208995A patent/BE894376A/fr not_active IP Right Cessation
- 1982-09-13 JP JP57158240A patent/JPS5857315A/ja active Granted
- 1982-09-13 GB GB08226087A patent/GB2105590B/en not_active Expired
- 1982-09-13 AT AT0341582A patent/AT385199B/de not_active IP Right Cessation
-
1992
- 1992-06-23 MX MX9203173A patent/MX9203173A/es unknown
-
1994
- 1994-02-21 BG BG98501A patent/BG60526B2/bg unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT3659B (en) | 1991-01-23 | 1996-01-25 | Isis Pharma Gmbh | Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions |
Also Published As
Publication number | Publication date |
---|---|
NL190746B (nl) | 1994-03-01 |
MX9203173A (es) | 1992-07-01 |
BG60526B2 (bg) | 1995-07-28 |
NL8203343A (nl) | 1983-04-05 |
NL190746C (nl) | 1994-08-01 |
GB2105590A (en) | 1983-03-30 |
DE3232873A1 (de) | 1983-03-31 |
FR2512676A1 (fr) | 1983-03-18 |
AT385199B (de) | 1988-02-25 |
JPH0341447B2 (fr) | 1991-06-24 |
GB2105590B (en) | 1985-05-30 |
ATA341582A (de) | 1987-08-15 |
IT8223147A0 (it) | 1982-09-07 |
CH652025A5 (de) | 1985-10-31 |
FR2512676B1 (fr) | 1987-01-23 |
IT1158048B (it) | 1987-02-18 |
JPS5857315A (ja) | 1983-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC1782A1 (fr) | Preparation pharmaceutique | |
FI822191L (fi) | Farmaceutisk blandning | |
DK68392A (da) | Farmaceutisk praeparat indeholdende cefuroximaxetil | |
DK237884D0 (da) | Farmaceutisk praeparat | |
PT73686A (pt) | Pharmaceutical formulation | |
DK481585A (da) | Farmaceutisk praeparat indeholdende anthracyclinglycosider | |
BE894376A (fr) | Preparation pharmaceutique | |
DK345682A (da) | Pharmaceutiske expienser | |
FI832197L (fi) | Farmaceutisk blandning | |
IT8248677A0 (it) | Formulazioni farmaceutiche | |
DE3279436D1 (de) | Corpuscules containing medicaments | |
FI810056L (fi) | Farmaceutiska foereningar | |
DK58983D0 (da) | Farmaceutisk praeparat | |
DK152219C (da) | Azopigmentpraeparater | |
DK288686D0 (da) | Farmaceutiske praeparater | |
FR2598617B1 (fr) | Composition pharmaceutique | |
DK32182A (da) | Flydende biocidt praeparat | |
FI831687L (fi) | Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar | |
DK314283D0 (da) | Farmaceutiske praeparater | |
FR2503161B1 (fr) | Nouvelles fluoroprostacyclines, leur preparation et leur application pharmaceutique | |
MC1371A1 (fr) | Preparations pharmaceutiques | |
MC1372A1 (fr) | Preparations pharmaceutiques | |
FI823690A0 (fi) | Aminocyklopentanestrar och deras framstaellning och farmaceutiska preparat | |
NL193821B (nl) | Farmaceutisch preparaat. | |
BE891013A (fr) | Compositions pharmaceutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: F. *HOFFMANN-LA ROCHE A.G. Effective date: 20020913 |